| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | "[2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide co-treated with SU 5402 co-treated with Chir 99021] results in decreased expression of HES5 mRNA" | 20865013 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of HES5 mRNA" | 21908764 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| D000079 | Acetaldehyde | Acetaldehyde affects the expression of HES5 mRNA | 22634333 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of HES5 mRNA | 22230336 |
| D000082 | Acetaminophen | [Clofibrate co-treated with Acetaminophen] affects the expression of HES5 mRNA | 17585979 |
| D000082 | Acetaminophen | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HES5 mRNA] | 17585979 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of HES5 mRNA | 21641981 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of HES5 mRNA | 16483693 |
| D003913 | Dextroamphetamine | Dextroamphetamine results in decreased expression of HES5 mRNA | 12558987 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of HES5 mRNA | 24685274 |
| D001280 | Atrazine | Atrazine results in decreased expression of HES5 mRNA | 25929836 |
| C487081 | belinostat | belinostat results in decreased expression of HES5 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of HES5 mRNA | 21871943 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [AHR protein binds to HES5 promoter] | 19654925 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of HES5 mRNA | 27195522 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of HES5 mRNA | 21839799 |
| C006780 | bisphenol A | bisphenol A results in decreased methylation of HES5 promoter | 27312807 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of HES5 mRNA | 25181051 |
| D002104 | Cadmium | Cadmium results in increased expression of HES5 mRNA | 21120746 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of HES5 mRNA | 22634333 |
| C473711 | Chir 99021 | "[2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide co-treated with SU 5402 co-treated with Chir 99021] results in decreased expression of HES5 mRNA" | 20865013 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of HES5 mRNA | 15862623 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in decreased expression of HES5 mRNA | 26272509 |
| D002994 | Clofibrate | [Clofibrate co-treated with Acetaminophen] affects the expression of HES5 mRNA | 17585979 |
| D002994 | Clofibrate | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HES5 mRNA] | 17585979 |
| C000541 | cyclopamine | cyclopamine results in decreased expression of HES5 mRNA | 21703336 |
| D003561 | Cytarabine | Cytarabine results in increased expression of HES5 mRNA | 21198554 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of HES5 mRNA | 25016146 |
| C024629 | dimethyl phthalate | dimethyl phthalate affects the expression of HES5 mRNA | 26924002 |
| C118739 | entinostat | entinostat results in decreased expression of HES5 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| D005419 | Flavonoids | Flavonoids results in increased expression of HES5 mRNA | 18035473 |
| D005473 | Fluoxetine | Fluoxetine results in increased expression of HES5 mRNA | 17033635|1980184 |
| D005473 | Fluoxetine | Fluoxetine results in increased expression of HES5 protein | 19801843 |
| C069837 | fullerene C60 | fullerene C60 affects the expression of HES5 mRNA | 19167457 |
| C004312 | glycidol | glycidol results in increased expression of HES5 mRNA | 24915197 |
| D007649 | Ketamine | Ketamine results in decreased expression of HES5 mRNA | 20080153 |
| C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of HES5 mRNA" | 21843347 |
| C042720 | mercuric bromide | mercuric bromide results in decreased expression of HES5 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| D008694 | Methamphetamine | [Methamphetamine co-treated with SCH 23390] results in decreased expression of HES5 mRNA | 19564919 |
| D008694 | Methamphetamine | Methamphetamine results in decreased expression of HES5 mRNA | 19564919 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of HES5 mRNA | 23203475|2800136 |
| C004925 | methylmercuric chloride | methylmercuric chloride affects the expression of HES5 mRNA | 21613230 |
| C020771 | methylmercury hydroxide | methylmercury hydroxide results in increased expression of HES5 mRNA | 21908764 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of HES5 mRNA | 26924002 |
| C523799 | MRK 003 | MRK 003 results in decreased expression of HES5 | 26115193 |
| C523799 | MRK 003 | MRK 003 results in decreased expression of HES5 mRNA | 19775282|2116925 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of HES5 mRNA | 25102026 |
| C028007 | nickel monoxide | nickel monoxide results in decreased expression of HES5 mRNA | 19167457 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of HES5 mRNA | 21703336 |
| C025589 | ochratoxin A | SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of HES5 mRNA] | 21703336 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in decreased expression of HES5 mRNA | 26272509 |
| C410127 | PCB 180 | PCB 180 results in decreased expression of HES5 mRNA | 21908764 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of HES5 mRNA | 26272509 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of HES5 mRNA | 19162173 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of HES5 mRNA | 23557933 |
| D020959 | Polyethylene | Polyethylene results in decreased expression of HES5 mRNA | 23203475 |
| D011374 | Progesterone | Progesterone results in decreased expression of HES5 mRNA | 21540246 |
| D011441 | Propylthiouracil | [Propylthiouracil results in increased abundance of Thyroxine] which results in increased expression of HES5 mRNA | 15862623 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of HES5 mRNA | 24780913 |
| C534628 | SCH 23390 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of HES5 mRNA | 19564919 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of HES5 mRNA | 23806026 |
| D019821 | Simvastatin | Simvastatin results in increased expression of HES5 mRNA | 19109527 |
| D012999 | Soman | Soman results in decreased expression of HES5 mRNA | 19281266 |
| C105686 | SU 5402 | "[2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide co-treated with SU 5402 co-treated with Chir 99021] results in decreased expression of HES5 mRNA" | 20865013 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of HES5 mRNA | 16443690 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of HES5 mRNA | 22298810 |
| D013974 | Thyroxine | [Propylthiouracil results in increased abundance of Thyroxine] which results in increased expression of HES5 mRNA | 15862623 |
| D014050 | Toluene | Toluene results in decreased expression of HES5 mRNA | 22967744 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of HES5 mRNA | 21934132 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of HES5 mRNA | 15901671 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of HES5 mRNA | 24935251|2627250 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of HES5 mRNA | 15901671 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of HES5 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of HES5 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of HES5 gene | 29154799 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HES5 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in decreased expression of HES5 mRNA | 26272509 |